Evidence map›Paper›PMID 28584157›Full record

ArticleAntimicrobial agents and chemotherapy2017

Menoctone Resistance in Malaria Parasites Is Conferred by M133I Mutations in Cytochrome

Lynn D Blake, Myles E Johnson, Sasha V Siegel, Adonis McQueen, Iredia D Iyamu, Abdul Kadar Shaikh, Michael W Shultis, Roman Manetsch, Dennis E Kyle

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Selection of CytochromeAntimicrobial agents and chemotherapy · 2021
    Article
  9. Article
  10. Article
  11. Selection ofProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lynn D BlakeDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
Myles E JohnsonDepartment of Global Health, College of Public Health, University of South Florida, Tampa, Florida, USA.
Sasha V SiegelDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
Adonis McQueenDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
Iredia D IyamuDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.
Abdul Kadar ShaikhDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.
Michael W ShultisDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.
Roman ManetschDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.
Dennis E KyleDepartment of Global Health, College of Public Health, University of South Florida, Tampa, Florida, USA dennis.kyle@uga.edu.
University of South Florida · USNortheastern University · US

Funding

Drugs targeting erythrocytic and exoerythrocytic stages of malariaR01GM097118 · NIGMS · UNIVERSITY OF SOUTH FLORIDA · PI MANETSCH, ROMAN · 2011 to 2015
$1.3M
Extreme Resistance to Mitochondrial Inhibitors in Plasmodium falciparumR21AI109530 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI KYLE, DENNIS E · 2014 to 2015
$391k
NIAID NIH HHS R21 AI109530NIGMS NIH HHS R01 GM097118
6 · The paper itself

Abstract

Malaria-related mortality has slowly decreased over the past decade; however, eradication of malaria requires the development of new antimalarial chemotherapies that target liver stages of the parasite and combat the emergence of drug resistance. The diminishing arsenal of anti-liver-stage compounds sparked our interest in reviving the old and previously abandoned compound menoctone. In support of these studies, we developed a new convergent synthesis method that was facile, required fewer steps, produced better yields, and utilized less expensive reagents than the previously published method. Menoctone proved to be highly potent against liver stages of

Indexed as

AnimalsAnophelesAntimalarialsAtovaquoneCytochromes bDNA, ProtozoanDrug ResistanceFemaleMalaria, FalciparumMiceMice, Inbred BALB CMutationNaphthoquinonesPlasmodium bergheiPlasmodium falciparumAntimalarialsAtovaquoneCytochromes bDNA, ProtozoanmenoctoneNaphthoquinonesantimalarial agentsdrug resistance mechanismsmenoctone

Identifiers

PMID28584157
PMCPMC5527649
OpenAlexW2623263898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.